Aidoc CEO Elad Walach recognized as one of Modern Healthcare’s 40 Under 40 

Walach’s nomination is highlighted by significant Aidoc milestones, including expanded partnerships, new products and revenue growth

Aidoc is proud to announce that CEO Elad Walach has been recognized by Modern Healthcare as one of the 40 Under 40 healthcare leaders for 2024. The program recognizes the healthcare industry’s rising stars aged 40 and under who contribute to a culture of innovation and help their organizations achieve and exceed financial, operational and clinical goals. This acknowledgment underscores Walach’s pivotal role in steering Aidoc through significant milestones, marked by expanded partnerships, the introduction of innovative products and substantial revenue growth.

“Being included in this esteemed roster of industry luminaries and innovators, who are all striving to transform healthcare, is a true honor,” says Elad Walach, Aidoc CEO. “Our journey, propelled by the dedication of our clinical partners and the exceptional teams at Aidoc, is a testament to the vision my co-founders and I established. Together, we remain steadfast in our commitment to advance patient care and make a tangible impact on a daily basis.”

Walach’s award nomination is highlighted several Aidoc milestones from 2023:

  • Expanded clinical offering: The company secured three FDA-clearances, now leading the industry with 16. Aidoc also added five new care coordination and patient management solutions for acute medical conditions that include deep vein thrombosis, aortic aneurysm and brain aneurysms.
  • Expanded clinical AI partnerships and growth: Aidoc reached agreements with dozens of new care providers, punctuated by Mayo Clinic Platform selecting Aidoc as the AI orchestration engine and Northwell Health integrating Aidoc’s aiOS across 17 of its clinical facilities. As a result of the expanded partnerships, Aidoc’s revenues grew by more than 60 percent.
  • Company clinical impact: The Aidoc aiOS™ doubled its monthly analysis of patient exams from 1 million to 2 million and demonstrated it could help reduce readmission rates by an average of 33 percent, leading to a potential of $4.5 million in annual cost savings.

“Our inaugural class of 40 Under 40 demonstrates the wide range of talent needed in healthcare today and in the years to come,” said Mary Ellen Podmolik, editor-in-chief of Modern Healthcare. “They are the rising stars who will propel the industry forward with a focus on innovation, efficiency, affordability and compassion.”

About Aidoc

Aidoc is a pioneering force in clinical AI. We focus on aiding and empowering healthcare teams to optimize patient treatment, which results in improved economic value and clinical outcomes. Our clinically proven AI solutions eliminate silos, increase efficiencies, and improve outcomes by delivering critical information when and where care teams need it, leading to immediate collective action. Built on Aidoc’s proprietary aiOS™, we analyze and aggregate medical data to enable care teams to operationalize the unexpected and work seamlessly with a continued focus on the patient. Used in more than 1,000 medical centers worldwide, Aidoc has the most FDA clearances (13) in clinical AI, and its AI-based solutions cover 75 percent of patient populations, enabling physicians to make informed decisions based on real-time data. Aidoc AI is always on, running in the background to change the foreground. Visit Aidoc.com to see how we are connecting all points of care with always-on AI.

About Modern Healthcare

Modern Healthcare is the most trusted business news and information brand in the healthcare industry. Modern Healthcare empowers healthcare leaders and influencers to make timely and informed business decisions.

Explore the Latest AI Insights, Trends and Research